Please login to the form below

Not currently logged in


This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

MaxCyte gets green light for solid tumour cell therapy

MaxCyte gets green light for solid tumour cell therapy

AIM-listed biotech MaxCyte has been cleared by the FDA to start trials of its chimeric antigen receptor (CAR) therapy for solid tumours, viewed as a tough challenge for this new

Latest news

More from news
Approximately 587 fully matching, plus 1,337 partially matching documents found.

Latest Intelligence

  • 30 women leaders in UK healthcare (part 3) 30 women leaders in UK healthcare (part 3)

    2004. Fifteen years on, the company’s lead product candidate, Lynovex, for the treatment of acute pulmonary exacerbations in Cystic Fibrosis, was recently granted FDA Fast Track Designation.

  • A new era of smart pharma A new era of smart pharma

    The FDA recently approved a ‘digital pill’. The pill includes an embedded sensor that digitally tracks if patients have ingested it.

  • Significant figures Significant figures

    US regulators at the FDA have recognised the treatment’s potential, handing it breakthrough and fast-track status.

  • Deal Watch January 2018

    In October 2017 GSK's QS-21 Stimulon herpes zoster vaccine, Shingrix, was approved by the FDA.

  • Drug safety

    Healthcare terms - Drug safety.

More from intelligence
Approximately 2 fully matching, plus 95 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 42 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

StratX creates experiential learning programs instilled with emotion and competitive spirit, leading to lasting on-the-job change. Our memorable approach develops...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....